PATH pushes a unified automation platform as enterprises consolidate tools, supporting ARR growth, stronger pilots and ...

Elon explicitly pushed back on today’s Business Insider “Macrohard stalled → pivot to Tesla” FUD. XAI minor staff churn, ...

UiPath’s PATH advantage in the current automation race lies in how effectively its platform converts AI innovation into consistent enterprise efficiency. The company is moving beyond traditional ...

"We're also providing a scalable blueprint to expand agentic automation across the enterprise, transforming how business users engage with ERP through seamless collaboration betwe ...

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.

UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...

Dines spotlighted Maestro, UiPath's orchestration engine, and recent product wins, including a semiconductor company deploying agentic workflows in under two weeks and One New Zealand, which reduced a ...

UiPath reported top- and bottom-line gains in the fiscal fourth quarter, but its stock declined after the company guided for a slowdown in full-year revenue growth.

UiPath closes fiscal year 2026 on a high, with co-Founder and CEO Daniel Dines making a bold case that falling AI development costs are good for the automation market, not a threat to it.

The trend toward using AI technology to automate tasks previously performed manually is accelerating, and tools that automate operations on web browsers appear to be particularly useful for many users ...